Gel-forming mucins secreted into the airways are thought to protect the lungs by clearance of inhaled pathogens and particulates. However, mucin hypersecretion can cause airflow obstruction and airway injury. Therefore, tight control of mucin secretion is critical for airway homeostasis. Munc18 proteins are essential components of the regulated secretory machinery of eukaryotic cells, such that their absence causes complete failure of secretion. We find that Munc18b is expressed at the apical membrane of airway secretory cells, and that heterozygous Munc18b null mice have a defect in airway mucin secretion. Since homozygous Munc18b null mice are not viable, we have generated conditional Munc18b deletant mice with a loss-of-function only in airway secretory cells. We have also generated transgenic mice overexpressing a gain-of-function Munc18b mutant in airway secretory cells. We hypothesize that the mice with Munc18b deleted in their airway secretory cells will completely fail to secrete airway mucins at baseline or with stimulation, and that the transgenic mice will hypersecrete airway mucins. These hypotheses will be tested in the following Specific Aims: 1) Assess changes in the structure of the airways of Munc18b null and transgenic mutant mice. 2) Determine baseline and stimulated secretory function in Munc18b null and transgenic mutant mice. The proposed studies will advance understanding of the structure and function of the airway secretory mechanism, and provide essential reagents for future studies to test the putative protective and pathologic roles of mucin secretion in lung diseases.

Public Health Relevance

Mucus in the airways is needed to protect the lungs against inhaled particles and infections. On the other hand, too much mucus blocks the airways in cystic fibrosis and asthma. We will study how mucus is secreted into the airways to determine how this can be optimized for treatment of lung diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21HL094848-02
Application #
7901030
Study Section
Lung Cellular, Molecular, and Immunobiology Study Section (LCMI)
Program Officer
Banks-Schlegel, Susan P
Project Start
2009-08-01
Project End
2011-07-31
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
2
Fiscal Year
2010
Total Cost
$192,500
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Piccotti, Lucia; Dickey, Burton F; Evans, Christopher M (2012) Assessment of intracellular mucin content in vivo. Methods Mol Biol 842:279-95
Kim, Kyubo; Petrova, Youlia M; Scott, Brenton L et al. (2012) Munc18b is an essential gene in mice whose expression is limiting for secretion by airway epithelial and mast cells. Biochem J 446:383-94
Kanashiro-Takeuchi, Rosemeire M; Takeuchi, Lauro M; Hatzistergos, Konstantinos et al. (2011) Effects of combination of proliferative agents and erythropoietin on left ventricular remodeling post-myocardial infarction. Clin Transl Sci 4:168-74
Evans, Scott E; Xu, Yi; Tuvim, Michael J et al. (2010) Inducible innate resistance of lung epithelium to infection. Annu Rev Physiol 72:413-35
Kanashiro-Takeuchi, Rosemeire M; Tziomalos, Konstantinos; Takeuchi, Lauro M et al. (2010) Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc Natl Acad Sci U S A 107:2604-9
Tuvim, Michael J; Mospan, Andrea Rossi; Burns, Kimberlie A et al. (2009) Synaptotagmin 2 couples mucin granule exocytosis to Ca2+ signaling from endoplasmic reticulum. J Biol Chem 284:9781-7